Suboptimal concordance in testing and retesting results of triple-negative breast carcinoma cases among laboratories: one institution experience

Abstract Background Triple-negative breast carcinoma (TNBC) patients do not benefit from hormone- or human epidermal growth factor receptor 2- (HER2-) targeted therapies. Accurate testing is pivotal for these patients. Methods TNBC cases that were retested at our institution during a 3-year period w...

Cijeli opis

Bibliografski detalji

Glavni autori:	Jose De Jesus, Marilin Rosa
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2019-10-01
Serija:	Cancer Cell International
Teme:	Concordance testing Dual in situ hybridization Estrogen receptor Fluorescence in situ hybridization Human epidermal growth factor receptor 2 immunohistochemistry In situ hybridization
Online pristup:	http://link.springer.com/article/10.1186/s12935-019-0987-7
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!